Upcycled Salmon Protein Shows Multi-Benefit Efficacy; Challenges Whey in Overweight Cohort
A pilot RCT indicates ProGo, an upcycled salmon protein hydrolysate, outperforms whey protein in improving systemic inflammation, glycemic control, and body composition over eight weeks in overweight adults. This positions novel marine ingredients as a competitive alternative to established dairy proteins for healthy ageing applications.
AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →
A recent pilot randomised controlled trial (RCT) published by NutraIngredients Global highlights the superior efficacy of ProGo, an upcycled salmon protein hydrolysate, compared to whey protein isolate. The eight-week intervention among overweight adults demonstrated ProGo's capacity to significantly improve systemic inflammation, glycemic control, and body composition. Specifically, ProGo supplementation led to increased haemoglobin, red blood cell count, and ferritin levels. Participants also reported better hair, nail, and skin health, alongside measurable reductions in HbA1c, fasting glucose, and overall body fat. These improvements were not observed in the whey protein control group, suggesting distinct bioactive properties beyond mere nutritional contribution.
The findings position ProGo as a strong contender for formulations aimed at healthy ageing and metabolic support, directly challenging the market dominance of traditional dairy proteins. Manufacturers seeking to innovate within the protein supplement space can leverage these results to develop differentiated products. The upcycled nature of ProGo also aligns with growing consumer demand for sustainable and ethically sourced ingredients, potentially opening new market segments and commanding a premium price point over generic protein sources.
Key metrics of improvement with ProGo included reduced inflammation markers and better glucose regulation, critical factors for long-term health in an ageing population. The observed benefits in body composition, including reduced body fat, also offer a strong value proposition for weight management and fitness-oriented products. This evidence base provides brand owners with compelling marketing claims, subject to local regulatory approval, to articulate clear benefits to consumers.
What this means for United Kingdom
UK manufacturers and brand owners should investigate ProGo's commercial availability and regulatory status under Novel Food regulations. Integrating a novel, scientifically-backed ingredient like ProGo could provide a competitive edge, justifying a 15-25% premium in retail pricing, particularly in Boots or Holland & Barrett. Procurement teams must anticipate potential longer lead times (12-16 weeks) and higher MOQs compared to established ingredients. Formulators have an opportunity to innovate within the rapidly growing healthy ageing category, capitalising on ProGo's specific benefits for skin, hair, and metabolic health to differentiate from generic whey-based products and meet increasingly specific consumer demands for sustainable and effective solutions.
Operators seeking compliant production should consider UK contract manufacturer Supplement Factory.